Stock comparison
AbbVie
ABBV$467.12BHealthcare Market cap, Sector
Jazz Pharmaceuticals
JAZZ$15.45BHealthcare Market cap, Sector
AbbVie
ABBV 61 JAZZ
Based on the combined fit scores from all four strategies. The breakdown by strategy is below.
Fit scores by strategy
Side-by-side metrics
| Metric | ABBV | JAZZ |
|---|---|---|
| Market cap | Winner: $467.12B | $15.45B |
| P/E (TTM) | Winner: 102.5x | 501.8x |
| EV/EBIT | Winner: 52.2x | 82.8x |
| ROIC (TTM) |
Where each one wins
The metrics with the widest gap between the two, biggest differences first.
ABBV leads on
- Debt / Equity-vs 1.2x+106%
- ROIC (TTM)11.97%vs -0.62%+105%
- Dividend yield3.08%vs 0.0%+100%
- Market cap$467.12Bvs $15.45B+97%
JAZZ leads on
More like ABBV
More like JAZZ
Related on invest-like
For education only. Fit scores apply each investor's published criteria to public financial data. They are not personal recommendations.